Key Takeaways:
- RDS achieves a significant milestone with the CE mark approval for its MultiSense® Remote Patient Monitoring solution, positioning the company for European market entry.
- The innovative wearable device enables real-time monitoring of six vital signs, fostering improved patient outcomes and transformative care pathways.
- RDS prepares for a Series A funding round to support product commercialization across Europe and expansion into the US market by 2025.
Strasbourg, France, March 5, 2024 – In a groundbreaking development, RDS, the cutting-edge medical device startup, proudly announces the attainment of the CE mark for its revolutionary MultiSense® Remote Patient Monitoring solution. This achievement signifies a pivotal regulatory milestone, paving the way for the commercialization of an innovative healthcare solution poised to redefine patient care across Europe and beyond.
Empowering Healthcare Innovation: The MultiSense® Breakthrough
The CE mark accreditation underscores RDS’s unwavering commitment to innovation and excellence in medical technology. MultiSense® represents a paradigm shift in patient monitoring, offering a comprehensive solution that seamlessly integrates wearable technology with advanced cloud-based analytics. With real-time tracking of six physiological parameters, including heart rate, respiratory rate, and oxygen saturation, MultiSense® empowers healthcare professionals to deliver personalized care tailored to each patient’s needs.
Stéphanie Hilbold, Director of Quality Assurance and Regulatory Affairs at RDS, emphasizes, “Achieving this pivotal milestone is testament to the hard work of our technical development teams in recent years, working in close collaboration with the RDS department for quality assurance and regulatory affairs.”
Transforming Patient Pathways: The Impact of MultiSense®
MultiSense® heralds a new era of patient-centric care, enabling medical teams to monitor vital signs remotely and proactively intervene when necessary. By facilitating Enhanced Recovery After Surgery (ERAS) protocols and supporting post-surgery patients’ transition to home care, MultiSense® revolutionizes traditional care pathways and enhances patient outcomes.
Elie Lobel, CEO of RDS, affirms, “The CE mark represents another important step on the path to marketing our solution in Europe. Clinicians have shown a keen interest in our device and its potential to transform patient pathways.”
Pioneering Partnerships and Future Growth: RDS’s Expansion Strategy
RDS’s visionary approach extends beyond regulatory milestones, with strategic partnerships driving innovation and expansion. Collaborative initiatives with leading healthcare institutions, including Amiens-Picardie University Hospital and major cancer centers in France, underscore MultiSense®’s role as a catalyst for transformative healthcare solutions.
Looking ahead, RDS embarks on a Series A funding round to fuel product commercialization, expand clinical trials, and secure regulatory approval for the US market. With the global remote patient monitoring market poised for exponential growth, RDS stands at the forefront of healthcare innovation, poised to deliver tangible benefits to patients and healthcare providers worldwide.
About RDS: Pioneering Excellence in Healthcare Technology
RDS is at the vanguard of healthcare innovation, spearheading the development and commercialization of MultiSense®, a next-generation Remote Patient Monitoring (RPM) solution. Leveraging cutting-edge technology and a commitment to excellence, RDS empowers healthcare professionals to deliver personalized, data-driven care that enhances patient outcomes and transforms healthcare delivery.
Sign up to our newsletter & get the most important monthly insights from around the world.
Ready to Amplify Your Brand with Business Today?
Discover the power of sponsored articles and partnerships to reach decision-makers, professionals, and a dynamic audience. Learn more about our advertising opportunities and connect with us today!
Click here to explore our Promotion & Sponsored Articles page.
Are you looking to make an impact? Contact us at [email protected] to get started!
